EDITORS-IN-CHIEF
Sam H. Ahmedzai
Sam is Emeritus Professor in the Medical School at University of Sheffield, UK, with 30 years’ experience of being consultant physician in palliative medicine, covering both acute hospital and hospice.
His Sheffield academic clinical department had an active program in care and research in cancer and non-cancer patients at all stage of illness from diagnosis to survivorship or end of life care. Sam was an early advocate of the concept of supportive care working alongside acute specialties of oncology and other diseases.
His research covers – biology of pain; management of symptoms of cancer and arising from its treatment; holistic needs and quality of life assessment; improving supportive and end of life care services for cancer and chronic disease patients; advocating patient and public involvement in cancer research.
Sam served as National Institute for Health Research (NIHR) national specialty lead for supportive care and community research; and he co-chaired the National Cancer Research Institute (NCRI) Living With and Beyond Cancer research group. He has worked with NICE to produce guidelines for care of people at the end of life.
He was a founding member of the Association for Palliative Medicine and he initiated the APM Science Committee.
In 2016 Sam was given the Lifetime Achievement Award by the British Thoracic Oncology Group and was also inducted as Honorary Fellow of the Faculty of Pain Medicine in the Royal College of Anaesthetists.
Edward Chow
Dr Edward Chow is a Professor in Department of Radiation Oncology, University of Toronto and a senior scientist at Sunnybrook Research Institute in Toronto, Canada
Anthony Dickenson
Anthony Dickenson, BSc, PhD, FmedSci, FBPharmcolS is Emeritus Professor of Neuropharmacology in the Department of Neuroscience, Physiology and Pharmacology at University College, London, UK. He gained his PhD at the National Institute for Medical Research, London, UK and has held posts in Paris, California and Sweden. His research interests are pharmacology of the brain, including the mechanisms of pain and how pain can be controlled in both normal and pathophysiological conditions, and how to translate basic science to the patient.
Professor Dickenson is an Honorary Member of the British Pain Society, was a Member of the Council of the International Association for the Study of Pain for six years and is Section Editor for the journal Pain. He has authored more than 360 refereed publications and has an h index of 106, all due to his motivated and brilliant research team. He is a founding and continuing Member of the Wellcome Trust funded London Pain Consortium.
Professor Dickenson has given plenary lectures at the World Congress on Pain, the American Pain Society, the European Pain Congress, the Canadian Pain Society, the Belgium Pain Society, ASEAPs, the Scandinavian Pain Society, the British Pain Society, the Thailand Pain Society, the Irish Pain Society, the Singapore Pain Society, the Australian Pain Society, the New Zealand Pain Society and many other international and national meetings. He has also spoken at the Royal Institution to GPs and to schools on pain.
SECTION EDITORS
Ines B. Menjak
Dr Ines B. Menjak is a medical oncologist at the Sunnybrook Odette Cancer Centre in Toronto, Canada. She is the founder and medical lead of the geriatric oncology program at the Odette Cancer Centre. She also specializes in the care of patients with melanoma and lung cancer. She completed her medical training at the University of Toronto, Canada, and completed a Master of Science in the Health Research Methodology Program at McMaster University, Canada. She is a recipient of the ASCO Young Investigator Award for her research in the geriatric assessment’s impact on decision making for patients with early-stage breast cancer. She continues her research focus on older patients with cancer, specifically the impact of geriatric assessment on functional outcomes.
Schroder Sattar
Schroder Sattar, RN PhD, is an Assistant Professor at the College of Nursing, University of Saskatchewan, Canada, and vice-chair of the Nursing & Allied Health group, International Society of Geriatric Oncology. Dr Sattar’s research focuses on functional performance, falls, and exercise interventions in older adults with cancer (geriatric oncology). She is currently conducting a randomized controlled trial to investigate the efficacy of a remotely delivered exercise training program on improvement of lower body strength and balance and fall prevention in older adults (age ≥65) with cancer. Dr Sattar obtained her BN training from the University of New Brunswick, Fredericton, Canada, and Masters and PhD in nursing from the University of Toronto, Canada.
Christopher Steer
Christopher is a medical oncologist at Border Medical Oncology at the Albury Wodonga Regional Cancer Centre in regional New South Wales, Australia. He is also an Associate Professor at the UNSW Rural Clinical School, Albury campus, Australia.
After completing training in medical oncology in 2000, Christopher travelled to London to work as a clinical research fellow at Kings College London, Guy’s and St Thomas’ hospital, UK. Whilst at Guy’s, Christopher developed an interest in gynaecological oncology and cancer in the older adult. Christopher was appointed to the MRC as the trial physician for the ICON5 study of combination chemotherapy in women with ovarian cancer.
Christopher has served as the co-chair of the MASCC geriatric study group. He has also served on the board of the International Society of Geriatric Oncology (SIOG) and was the chair of the national representative committee. He serves on the editorial board of the Journal of Geriatric Oncology. Christopher was chair of the scientific committee of the SIOG annual scientific meeting in Prague in 2016. He was the inaugural chair of the Clinical Oncological Society of Australia (COSA) geriatric interest group.
Christopher was a board member of the Medical Oncology Group of Australia (MOGA) and is the current President of the Private Cancer Physicians of Australia (PCPA). He is a member of ASCO, ESMO, IGCS, MOGA, COSA and MASCC.
Christopher is an investigator at the Border Medical Oncology Research Unit and strives to bring clinical trials to patients in regional Australia. He is co-lead of the geriatric oncology pillar of the Victorian Regional Trials Network ReVitalise Project that strives to improve access to clinical trials for patients living in regional Victoria. As the coordinator of Independent Learning Projects (ILPs) for the UNSW Rural Clinical School, Christopher works to foster research skills in local medical students and acts as a mentor for clinician investigators.
